127 related articles for article (PubMed ID: 3256563)
1. Single dose curative and prophylactic efficacy of antimalarial drugs against multi-resistant Plasmodium yoelii nigeriensis.
Shukla B; Dutta GP
J Commun Dis; 1988 Sep; 20(3):175-84. PubMed ID: 3256563
[No Abstract] [Full Text] [Related]
2. Resistance reversal action of ketoconazole against mefloquine resistance of Plasmodium yoelii nigeriensis.
Awasthi A; Dutta GP; Bhakuni V; Tripathi R
Exp Parasitol; 2004; 107(3-4):115-9. PubMed ID: 15363936
[TBL] [Abstract][Full Text] [Related]
3. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
Singh C; Malik H; Puri SK
J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
[TBL] [Abstract][Full Text] [Related]
4. Antimalarial herbs against chloroquine-resistant P. yoelii nigeriensis in mice.
Kimbi HK; Fagbenro-Beyioku AF; Oyibo WA
Indian J Malariol; 1998 Mar; 35(1):35-8. PubMed ID: 10319560
[No Abstract] [Full Text] [Related]
5. Azithromycin: antimalarial profile against blood- and sporozoite-induced infections in mice and monkeys.
Puri SK; Singh N
Exp Parasitol; 2000 Jan; 94(1):8-14. PubMed ID: 10631075
[TBL] [Abstract][Full Text] [Related]
6. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
[TBL] [Abstract][Full Text] [Related]
7. Orally active 1,2,4-trioxepanes: synthesis and antimalarial activity of a series of 7-arylvinyl-1,2,4-trioxepanes against multidrug-resistant Plasmodium yoelii in Swiss mice.
Singh C; Pandey S; Sharma M; Puri SK
Bioorg Med Chem; 2008 Feb; 16(4):1816-21. PubMed ID: 18054238
[TBL] [Abstract][Full Text] [Related]
8. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
[TBL] [Abstract][Full Text] [Related]
9. Search for new pharmacophores for antimalarial activity. Part III: synthesis and bioevaluation of new 6-thioureido-4-anilinoquinazolines.
Mishra A; Srivastava K; Tripathi R; Puri SK; Batra S
Eur J Med Chem; 2009 Nov; 44(11):4404-12. PubMed ID: 19586687
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
Neerja J; Puri SK
Exp Parasitol; 2004; 107(3-4):120-4. PubMed ID: 15363937
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the antimalarial properties and standardization of tablets of Azadirachta indica (Meliaceae) in mice.
Isah AB; Ibrahim YK; Iwalewa EO
Phytother Res; 2003 Aug; 17(7):807-10. PubMed ID: 12916083
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium yoelii nigeriensis (MDR)-efficacy of oral pyronaridine against multidrug-resistant malaria in Swiss mice.
Tripathi R; Umesh A; Mishra M; Puri SK; Dutta GP
Exp Parasitol; 2000 Mar; 94(3):190-3. PubMed ID: 10831384
[TBL] [Abstract][Full Text] [Related]
14. Induction of chloroquine resistance in Plasmodium yoelii nigeriensis.
Kimbi HK; Fagbenro-Beyioku AF
East Afr Med J; 1996 Oct; 73(10):634-5. PubMed ID: 8997840
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of new 6-alkylvinyl/arylalkylvinyl substituted 1,2,4-trioxanes active against multidrug-resistant malaria in mice.
Singh C; Gupta N; Puri SK
Bioorg Med Chem; 2004 Nov; 12(21):5553-62. PubMed ID: 15465332
[TBL] [Abstract][Full Text] [Related]
16. Linker-based hemisuccinate derivatives of artemisinin: synthesis and antimalarial assessment against multidrug-resistant Plasmodium yoelii nigeriensis in mice.
Singh C; Kanchan R; Chaudhary S; Puri SK
J Med Chem; 2012 Feb; 55(3):1117-26. PubMed ID: 22216834
[TBL] [Abstract][Full Text] [Related]
17. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
Ishih A; Miyase T; Ohori K; Terada M
Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
[TBL] [Abstract][Full Text] [Related]
18. Antagonist effect of chloroquine and tumor necrosis factor on hepatic oxidative stress and antioxidant defense in normal and Plasmodium yoelii nigeriensis-infected mice.
Siddiqi NJ; Alhomida AS; Dutta GP; Pandey VC
In Vivo; 2002; 16(1):67-70. PubMed ID: 11980364
[TBL] [Abstract][Full Text] [Related]
19. Anti-protozoan activities of Harungana madagascariensis stem bark extract on trichomonads and malaria.
Iwalewa EO; Omisore NO; Adewunmi CO; Gbolade AA; Ademowo OG; Nneji C; Agboola OI; Daniyan OM
J Ethnopharmacol; 2008 May; 117(3):507-11. PubMed ID: 18372133
[TBL] [Abstract][Full Text] [Related]
20. Status of hepatic oxidative stress and antioxidant defense systems during chloroquine treatment of Plasmodium yoelii nigeriensis infected mice.
Siddiqi NJ; Alhomida AS
In Vivo; 1999; 13(6):547-50. PubMed ID: 10757052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
